ELVN financials
Enliven Therapeutics (ELVN) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
ELVN income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $0.00 | -$263.00K | -$119.66M | -$103.69M | -1.83 |
| 2024 | $0.00 | $0.00 | -$104.55M | -$89.02M | -1.89 |
| 2023 | $0.00 | $0.00 | -$83.53M | -$71.58M | -2.01 |
| 2022 | $0.00 | $0.00 | -$38.79M | -$37.66M | -6.03 |
| 2021 | $0.00 | $0.00 | -$24.76M | -$24.74M | -3.17 |
| 2020 | $0.00 | $0.00 | -$9.32M | -$18.97M | -4.31 |